To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 120.80 |
Bid | 121.00 |
Ask | 122.00 |
Change | -0.60 (-0.49%) |
Volume | 470,930 |
Open | 121.00 |
High | 122.60 |
Low | 120.80 |
Prev. Close | 121.40 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 651.92m |
Market Capitalisation | £787.51m |
Market Size | 5,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 73 |
---|---|
Vol. Sold | 325,777 |
Sold Value | £395.50k |
Vol. Bought | 145,153 |
Bought Value | £176.89k |
PE Ratio | -14.41527 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 16:38:27 | 120.80 | 35,000 | Sell* | 121.00 | 122.00 | 42.28k | O Ordinary |
10-May-24 | 16:35:01 | 120.80 | 28,076 | Sell* | 121.00 | 122.00 | 33.92k | UT Uncrossing Trade |
10-May-24 | 16:26:28 | 121.00 | 3,468 | Sell* | 121.00 | 122.00 | 4,196 | A Automatic Execution |
10-May-24 | 16:24:09 | 121.493 | 823 | Sell* | 121.00 | 122.00 | 999.89 | O Ordinary |
10-May-24 | 16:22:48 | 121.494 | 4,000 | Sell* | 121.00 | 122.00 | 4,860 | O Ordinary |
10-May-24 | 16:21:38 | 121.494 | 6,000 | Sell* | 121.00 | 122.00 | 7,290 | O Ordinary |
10-May-24 | 16:19:49 | 121.499 | 3,950 | Sell* | 121.00 | 122.00 | 4,799 | O Ordinary |
10-May-24 | 16:16:52 | 122.00 | 66 | Buy* | 121.00 | 122.00 | 80.52 | A Automatic Execution |
10-May-24 | 16:04:28 | 121.00 | 4 | Sell* | 121.00 | 122.00 | 4.84 | A Automatic Execution |
10-May-24 | 15:42:20 | 121.50 | 3,000 | Buy* | 121.00 | 122.00 | 3,645 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients